- Home
- CSIQ vs IMTX Comparison
CSIQ vs IMTX Comparison
Compare CSIQ & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSIQ
- IMTX
- Stock Information
- Founded
- CSIQ 2001
- IMTX N/A
- Country
- CSIQ Canada
- IMTX Germany
- Employees
- CSIQ N/A
- IMTX N/A
- Industry
- CSIQ Semiconductors
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CSIQ Technology
- IMTX Health Care
- Exchange
- CSIQ Nasdaq
- IMTX Nasdaq
- Market Cap
- CSIQ 715.3M
- IMTX 579.8M
- IPO Year
- CSIQ 2006
- IMTX N/A
- Fundamental
- Price
- CSIQ $11.24
- IMTX $5.97
- Analyst Decision
- CSIQ Hold
- IMTX Strong Buy
- Analyst Count
- CSIQ 11
- IMTX 4
- Target Price
- CSIQ $16.49
- IMTX $14.67
- AVG Volume (30 Days)
- CSIQ 1.4M
- IMTX 677.1K
- Earning Date
- CSIQ 05-15-2025
- IMTX 05-13-2025
- Dividend Yield
- CSIQ N/A
- IMTX N/A
- EPS Growth
- CSIQ N/A
- IMTX N/A
- EPS
- CSIQ N/A
- IMTX N/A
- Revenue
- CSIQ $5,860,923,000.00
- IMTX $155,801,989.00
- Revenue This Year
- CSIQ $24.47
- IMTX N/A
- Revenue Next Year
- CSIQ $17.17
- IMTX $5.61
- P/E Ratio
- CSIQ N/A
- IMTX N/A
- Revenue Growth
- CSIQ N/A
- IMTX 93.56
- 52 Week Low
- CSIQ $6.57
- IMTX $3.30
- 52 Week High
- CSIQ $19.55
- IMTX $13.77
- Technical
- Relative Strength Index (RSI)
- CSIQ 62.22
- IMTX 65.69
- Support Level
- CSIQ $9.53
- IMTX $5.63
- Resistance Level
- CSIQ $10.65
- IMTX $6.16
- Average True Range (ATR)
- CSIQ 0.60
- IMTX 0.41
- MACD
- CSIQ 0.05
- IMTX 0.07
- Stochastic Oscillator
- CSIQ 86.36
- IMTX 78.89
About CSIQ Canadian Solar Inc. (ON)
Canadian Solar Inc is a Canadian solar technology and renewable energy company. It is a manufacturer of solar photovoltaic modules, a provider of battery energy storage solutions, and a developer of utility-scale solar power and battery energy storage projects.. It operates through two business segments CSI Solar and Recurrent Energy segment. The CSI Solar segment focused on solar modules and battery energy storage manufacturing and products. Its Recurrent segment focused on utility-scale solar power and battery energy storage project development and operation. Key revenue is generated from CSI Solar segment.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.